FDA approves broadest label in the industry for Oculogica’s EyeBOX® Concussion Diagnostic
Oculogica Inc., a pioneer in the development of non-invasive, objective diagnostic tools for brain injuries, is proud to announce that the U.S. Food and Drug Administration (FDA) has granted an expanded label for its groundbreaking EyeBOX® technology. The updated label permits clinicians to compare a patient with an injury against a normative population, allowing physicians […]